<DOC>
	<DOCNO>NCT01382368</DOCNO>
	<brief_summary>- Pulmonary disease increasingly important cause morbidity mortality modern world . - Sildenafil , orally administer phosphodiesterase type 5 ( PDE-5 ) inhibitor , target nitric oxide ( NO ) pathway . The drug first approve treatment Pulmonary Arterial Hypertension ( PAH ) 2005 . - The aim suggest study examine acute effect oral intake sildenafil exercise tolerance functional capacity Chronic Obstructive Pulmonary Disease ( COPD ) , Idiopathic pulmonary fibrosis ( IPF ) post Pneumonectomy patient . - The investigator hypothesize oral ingestion sildenafil prior exercise may enhance exercise tolerance improve function COPD , IPF post Pneumonectomy patient . - Patients Methods : Sixty chronic lung disease patient male female ( age 30 90 year ) 20 COPD ( GOLD III-IV ) [ 9 , 39 ] , 20 IPF 20 post Pneumonectomy patient recruit study . - All subject carry two maximal cardiopulmonary exercise test ( CPET ) bicycle ergometer different day ; 60 min intake placebo 60 min intake 100 mg sildenafil ( Pfizer , Sandwich , UK ) , random order . - In first meeting prior exercise test rest standard pulmonary function test , diffusion CO , TLC RV measure . In addition , Doppler Echocardiography blood sample NT-proBNP take prior post CPET . - After 15-20 minute passive recovery post exercise test patient perform 3 short functional test include 6 minute walk test ass functional capacity .</brief_summary>
	<brief_title>Acute Effect Sildenafil Exercise Tolerance Functional Capacity COPD , IPF Post Pneumonectomy Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>1 . Patients severe COPD GOLD stage III IV , FEV1 3050 % le predicted value , great shortness breath , reduce exercise capacity , repeat excretion and\ chronic respiratory failure [ 9 , 39 ] . 2 . IPF patient diagnose essentially accord American Thoracic European Respiratory Societies ( ATSERS ) clinical diagnostic criterion : ( ) Highresolution compute tomography ( HRCT ) demonstrate pattern `` confident '' `` possible '' IPF ( b ) Abnormal pulmonary physiology evidence restriction and/or impair gas exchange ( exist exercise alone ) ( c ) Exclusion know cause interstitial lung disease ( e.g . : connective tissue disease , environmental exposure , etc. ) [ 31 ] . 3 . Patients post Pneumonectomy 6 month amputation surgery diagnosis ( Cancer , Trauma , Infection Bronchiectasis ) . 1 . Patients know sensitivity contraindication phosphodiesterase 5 ( PDE5 ) inhibitor therapy exclude study . 2 . Thromboembolic disease exclude pulmonary CTangiography perfusion scan . 3 . Patients history leftsided heart failure exclude . 4 . Patients also exclude regular treatment nitrate PDE5 inhibitor ( Sildenafil , Tadalafil , Vardenafil ) .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Post Pneumonectomy Patients</keyword>
	<keyword>IPF</keyword>
	<keyword>COPD</keyword>
</DOC>